Cargando…
HIV-associated cardiovascular disease: importance of platelet activation and cardiac fibrosis in the setting of specific antiretroviral therapies
HIV infection is a risk factor for cardiovascular disease (CVD). This risk is accentuated by certain combination antiretroviral therapies (cARTs), independent of their effects on lipid metabolism and insulin sensitivity. We sought to define potential mechanisms for this association through systemati...
Autores principales: | Laurence, Jeffrey, Elhadad, Sonia, Ahamed, Jasimuddin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6045710/ https://www.ncbi.nlm.nih.gov/pubmed/30018781 http://dx.doi.org/10.1136/openhrt-2018-000823 |
Ejemplares similares
-
HIV protease inhibitor-induced cardiac dysfunction and fibrosis is mediated by platelet-derived TGF-β1 and can be suppressed by exogenous carbon monoxide
por: Laurence, Jeffrey, et al.
Publicado: (2017) -
Blocking CXCL9 Decreases HIV-1 Replication and Enhances the Activity of Prophylactic Antiretrovirals in Human Cervical Tissues
por: Macura, Sherrill L., et al.
Publicado: (2016) -
Pan PPAR agonist IVA337 is effective in prevention and treatment of experimental skin fibrosis
por: Ruzehaji, Nadira, et al.
Publicado: (2016) -
Long COVID endotheliopathy: hypothesized mechanisms and potential therapeutic approaches
por: Ahamed, Jasimuddin, et al.
Publicado: (2022) -
Involvement of platelet-derived VWF in metastatic growth of melanoma in the brain
por: Robador, Jose R, et al.
Publicado: (2021)